Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Netherlands Brief.
Press releases published on April 1, 2025
Spotter Global to Revolutionize Drone and Pilot Detection with Upcoming Availability of RDID in Q2 2025
EIN Presswire
·
April 1, 2025
The incredibly low-cost RDID solution detects and tracks drones and drone pilots over a wide radius and can be easily transferred to new locations. OREM, UT, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- [Orem, Utah] – [March 17, 2025] – Spotter …
Quorum Software Launches Global Partner Advantage Program
EIN Presswire
·
April 1, 2025
Empowering Collaboration and Accelerating Partner Success HOUSTON, TX, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- Quorum Software, a global leader in energy software, today announced the launch of the Quorum Partner Advantage Program, a …
WoodWing en Open Connections bundelen krachten voor leidende informatiemanagement-oplossingen in het Verenigd Koninkrijk
EIN Presswire
·
April 1, 2025
LONDON, UNITED KINGDOM, April 1, 2025 /EINPresswire.com/ -- WoodWing kondigt vandaag een strategische samenwerking aan met Open Connections om haar krachtige informatie management-oplossing WoodWing Xtendis voor informatie- en documentbeheer beschikbaar …
Stellantis Annual General Meeting Live Webcast Available
GlobeNewswire
·
April 1, 2025
Stellantis Annual General Meeting Live Webcast Available AMSTERDAM, April 1, 2025 – Stellantis N.V. announced today that a link for the live webcast of its Annual General Meeting for the approval of Stellantis N.V.’s 2024 financial statements will be made …
Merus to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 1, 2025
UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®, Triclonics® and ADClonics …
Merus nimmt an Kamingespräch auf der 24. jährlichen Needham Virtual Healthcare Conference teil
GlobeNewswire
·
April 1, 2025
UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, April 01, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein Unternehmen für klinische Onkologie, das innovative, multispezifische Antikörper in voller Länge und Antikörper-Wirkstoff-Konjugate ( …
Merus participera à une discussion informelle lors de la 24e conférence annuelle Needham Virtual Healthcare
GlobeNewswire
·
April 1, 2025
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachussets, 01 avr. 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), entreprise spécialisée en oncologie développant des anticorps de pleine longueur multispécifiques et des conjugués anticorps-médicament …
Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission
GlobeNewswire
·
April 1, 2025
ZUG, Switzerland, April 01, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases …
CIRRO Fulfillment renforce ses activités françaises avec un nouveau centre de distribution en région parisienne
GlobeNewswire
·
April 1, 2025
PARIS, 01 avr. 2025 (GLOBE NEWSWIRE) -- CIRRO Fulfillment, fournisseur mondial de services de distribution e-commerce qui exerce ses activités en France sous l’entité juridique JS LOGISTICS, annonce l’extension de ses capacités de stockage et de ses …
Progress on share buyback programme
GlobeNewswire
·
April 1, 2025
Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 31 October 2024, in total 2,754,057 shares were repurchased during the week of 24 March 2025 up to and including 28 March 2025. …
ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights
GlobeNewswire
·
April 1, 2025
Received FDA authorization and recorded first commercial sales of ARC-EX System Secured strategic investment from Ottobock and extended cash runway for two years Gained exclusive rights to premier brain-computer interface technology EINDHOVEN, The …
ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice 2024 et partage ses faits marquants du début de l’année 2025
GlobeNewswire
·
April 1, 2025
Obtention de l’autorisation de la FDA et premières ventes commerciales du système ARC-EX Investissement stratégique d’Ottobock et extension de la visibilité financière sur deux ans Obtention de droits exclusifs sur une technologie de pointe d’interface …